Analysis of BRCA1 and BRCA2 alternative splicing in predisposition to ovarian cancer-Reference-Cited by-同舟云学术

Analysis of BRCA1 and BRCA2 alternative splicing in predisposition to ovarian cancer

Published:2023-04 Issue: Volume:130 Page:104856
ISSN:0014-4800
Container-title:Experimental and Molecular Pathology
language:en
Short-container-title:Experimental and Molecular Pathology

Author:

Jasiak Anna,Koczkowska Magdalena,Stukan Maciej,Wydra Dariusz,Biernat Wojciech,Izycka-Swieszewska Ewa,Buczkowski Kamil,Eccles Michael R.,Walker Logan,Wasag Bartosz,Ratajska Magdalena

Funder

University of Otago

Medical University of Gdansk

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Molecular Biology,Pathology and Forensic Medicine

Reference55 articles.

1. BRCA2 deep intronic mutation causing activation of a cryptic exon: opening toward a new preventive therapeutic strategy;Anczuków;Clin. Cancer Res.,2012

2. Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1;Ars;Hum. Mol. Genet.,2000

3. Splicing in action: assessing disease causing sequence changes;Baralle;J. Med. Genet.,2005

4. Cancer of the ovary, fallopian tube, and peritoneum: 2021 update;Berek;Int. J. Gynecol. Obstet.,2021

5. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J. Clin.,2018

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Functional Characterization of the Human BRCA1 ∆11 Splicing Isoforms in Yeast;International Journal of Molecular Sciences;2024-07-09

2. A Molecular Characterization of the Allelic Expression of the BRCA1 Founder Δ9–12 Pathogenic Variant and Its Potential Clinical Relevance in Hereditary Cancer;International Journal of Molecular Sciences;2024-06-20